Showing 261 - 280 results of 443 for search '"Parkinson's Disease"', query time: 0.05s Refine Results
  1. 261
    Cognition Deficits in Parkinson’s Disease: Mechanisms and Treatment

    Cognition Deficits in Parkinson’s Disease: Mechanisms and Treatment by Congcong Fang, Longqin Lv, Shanping Mao, Huimin Dong, Baohui Liu

    Published 2020-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 262
    Automated Subfield Volumetric Analysis of Hippocampus in Patients with Drug-Naïve Nondementia Parkinson’s Disease

    Automated Subfield Volumetric Analysis of Hippocampus in Patients with Drug-Naïve Nondementia Parkinson’s Disease by Jin-Woo Park, Chan-Nyoung Lee, Youngbo Sim, Hyung-Kyu Ham, Woo-Suk Tae, Byung-Jo Kim

    Published 2019-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 263
    Recurrent Falls in People with Parkinson’s Disease without Cognitive Impairment: Focusing on Modifiable Risk Factors

    Recurrent Falls in People with Parkinson’s Disease without Cognitive Impairment: Focusing on Modifiable Risk Factors by Lorena R. S. Almeida, Guilherme T. Valença, Nádja N. Negreiros, Elen B. Pinto, Jamary Oliveira-Filho

    Published 2014-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 264
    A Review of Dual-Task Walking Deficits in People with Parkinson's Disease: Motor and Cognitive Contributions, Mechanisms, and Clinical Implications

    A Review of Dual-Task Walking Deficits in People with Parkinson's Disease: Motor and Cognitive Contributions, Mechanisms, and Clinical Implications by Valerie E. Kelly, Alexis J. Eusterbrock, Anne Shumway-Cook

    Published 2012-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 265
    Quantitative Analysis of Motor Status in Parkinson’s Disease Using Wearable Devices: From Methodological Considerations to Problems in Clinical Applications

    Quantitative Analysis of Motor Status in Parkinson’s Disease Using Wearable Devices: From Methodological Considerations to Problems in Clinical Applications by Masahiko Suzuki, Hiroshi Mitoma, Mitsuru Yoneyama

    Published 2017-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 266
    Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical Practice

    Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical Practice by Khashayar Dashtipour, Fiona Gupta, Robert A. Hauser, Cherian A. Karunapuzha, John C. Morgan

    Published 2021-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 267
    Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson’s Disease

    Nicotine Has a Therapeutic Window of Effectiveness in a Drosophila melanogaster Model of Parkinson’s Disease by Brady T. Mannett, Braden C. Capt, Krista Pearman, Lori M. Buhlman, John M. VandenBrooks, Gerald B. Call

    Published 2022-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 268
    Predictors of Functional and Quality of Life Outcomes following Deep Brain Stimulation Surgery in Parkinson’s Disease Patients: Disease, Patient, and Surgical Factors

    Predictors of Functional and Quality of Life Outcomes following Deep Brain Stimulation Surgery in Parkinson’s Disease Patients: Disease, Patient, and Surgical Factors by Hesham Abboud, Gencer Genc, Nicolas R. Thompson, Srivadee Oravivattanakul, Faisal Alsallom, Dennys Reyes, Kathy Wilson, Russell Cerejo, Xin Xin Yu, Darlene Floden, Anwar Ahmed, Michal Gostkowski, Ayman Ezzeldin, Hazem Marouf, Ossama Y. Mansour, Andre Machado, Hubert H. Fernandez

    Published 2017-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 269
    Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson’s Disease? The Potential Role of Zolpidem in the Treatment of Parkinson’s Disease

    Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson’s Disease? The Potential Role of Zolpidem in the Treatment of Parkinso... by Antonio Daniele, Francesco Panza, Antonio Greco, Giancarlo Logroscino, Davide Seripa

    Published 2016-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 270
    N-Acetylcysteine in Combination with IGF-1 Enhances Neuroprotection against Proteasome Dysfunction-Induced Neurotoxicity in SH-SY5Y Cells

    N-Acetylcysteine in Combination with IGF-1 Enhances Neuroprotection against Proteasome Dysfunction-Induced Neurotoxicity in SH-SY5Y Cells by Benxu Cheng, Pinki Anand, Anxiu Kuang, Feroz Akhtar, Virginia L. Scofield

    Published 2016-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 271
    Spinal Cord Pathology in Alpha-Synuclein Transgenic Mice

    Spinal Cord Pathology in Alpha-Synuclein Transgenic Mice by Sonja Mendritzki, Saskia Schmidt, Teresa Sczepan, Xin-Ran Zhu, Daniel Segelcke, Hermann Lübbert

    Published 2010-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 272
    Serum Adiponectin Levels in Advanced-Stage Parkinson's Disease Patients

    Serum Adiponectin Levels in Advanced-Stage Parkinson's Disease Patients by Erica Cassani, Raffaella Cancello, Ferruccio Cavanna, Sabrina Maestrini, Anna Maria Di Blasio, Antonio Liuzzi, Gianni Pezzoli, Michela Barichella

    Published 2011-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 273
    Therapeutic Role of Protein Tyrosine Phosphatase 1B in Parkinson’s Disease via Antineuroinflammation and Neuroprotection In Vitro and In Vivo

    Therapeutic Role of Protein Tyrosine Phosphatase 1B in Parkinson’s Disease via Antineuroinflammation and Neuroprotection In Vitro and In Vivo by Chien-Wei Feng, Nan-Fu Chen, Te-Fu Chan, Wu-Fu Chen

    Published 2020-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 274
    Gastrointestinal Dysfunctions Are Associated with IL-10 Variants in Parkinson’s Disease

    Gastrointestinal Dysfunctions Are Associated with IL-10 Variants in Parkinson’s Disease by Li Shu, Dongxiao Liang, Hongxu Pan, Qian Xu, Xinxiang Yan, Beisha Tang, Qiying Sun

    Published 2018-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 275
    Executive Function and Postural Instability in People with Parkinson’s Disease

    Executive Function and Postural Instability in People with Parkinson’s Disease by Dong Xu, Michael H. Cole, Kerrie Mengersen, Peter A. Silburn, Feng Qiu, Cara Graepel, Graham K. Kerr

    Published 2014-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 276
    Olfactory Loss in Parkinson's Disease

    Olfactory Loss in Parkinson's Disease by Antje Haehner, Thomas Hummel, Heinz Reichmann

    Published 2011-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 277
    Sacral Reflex Characteristics of Patients with Multiple System Atrophy

    Sacral Reflex Characteristics of Patients with Multiple System Atrophy by Zhifang Pan, Xueming Zhang, Xun Wang, Binbin Deng, Wanli Zhang, Huanjie Huang

    Published 2020-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 278
    Deep Brain Stimulation of Caudal Zona Incerta and Subthalamic Nucleus in Patients with Parkinson's Disease: Effects on Diadochokinetic Rate

    Deep Brain Stimulation of Caudal Zona Incerta and Subthalamic Nucleus in Patients with Parkinson's Disease: Effects on Diadochokinetic Rate by Fredrik Karlsson, Elin Unger, Sofia Wahlgren, Patric Blomstedt, Jan Linder, Erik Nordh, Hamayun Zafar, Jan van Doorn

    Published 2011-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 279
    Role of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease

    Role of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease by Eunju Shin, Elisabetta Tronci, Manolo Carta

    Published 2012-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 280
    Frontostriatal Cognitive Staging in Parkinson's Disease

    Frontostriatal Cognitive Staging in Parkinson's Disease by Raúl de la Fuente-Fernández

    Published 2012-01-01
    “…Parkinson's Disease…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: